Exploring point-of-care testing of capillary blood in warfarin management

Journal of Pharmacy Practice and Research

Volumn 38, Issue 4, 2008, Pages 300-304

  Glover, Sharna ^a   Bajorek, Beata V ^b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ANTICOAGULATION; ARTICLE; CAPILLARY BLOOD; CLINICAL COMPETENCE; COST EFFECTIVENESS ANALYSIS; DESCRIPTIVE RESEARCH; EXPLORATORY RESEARCH; HEALTH CARE PERSONNEL; HUMAN; LONG TERM CARE; MEDICAL PRACTICE; PATIENT MONITORING; PATIENT SELECTION; POINT OF CARE TESTING; PROFESSIONAL KNOWLEDGE;

EID: 59849085137     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.2055-2335.2008.tb00394.x     Document Type: Article

References (25)

1. Cardiovascular Expert Writing Group. Therapeutic guidelines: cardiovascular. 4th ed. North Melbourne: Therapeutic Guidelines Limited; 2003. pp. 117, 126, 178.
2. Lowery S, Haley K, Bussey HI. Oral anticoagulation: challenges in the case-management setting. Lippincotts Case Manag 2005; 10: 39-50.
3. Bussey HI. How to monitor the dosage of warfarin. Heart Dis Stroke 1993; 2: 388-92.
4. Sawicki PT. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. JAMA 1999; 281: 145-50.
5. Borosak M. Warfarin: balancing the benefits and harms. Aust Preset 2004; 27: 88-92.
6. Khoo A, Bajorek BV. Extended roles for pharmacists in warfarin therapy: Identifying opportunities for pharmacist prescribing. J Pharm Pract Res 2006; 36: 190-3.
7. Lodwick AD, Sajbel TA. Patient and physician satisfaction with a pharmacist-managed anticoagulation clinic: implications for managed care organizations. Manag Care Q 2000; 9: 47-50.
8. Woods K, Douketis JD, Schnurr T, Kinnon K, Powers P, Crowther MA. Patient preferences for capillary vs. venous INR determination in an anticoagulation clinic: a randomized controlled trial. Thrombosis Res 2004; 114: 161-5.
9. Jackson SL, Bereznicki LR, Peterson GM, Marsden KA, Jupe DM, Vial JH, et al. Accuracy and clinical usefulness of the near-patient testing CoaguChek S international normalised ratio monitor in rural medical practice. Aust J Rural Health 2004; 12: 137-42.
10. Havrda DE, Hawk TL, Marvin CM. Accuracy and precision of the CoaguChek S versus laboratory INRs in a clinic. Ann Pharmacother 2002; 36: 769-75.
11. Jackson SL, Bereznicki LR, Peterson GM, Marsden KA, Jupe DM, Tegg E, et al. Accuracy, reproducibility and clinical utility of the CoaguChek S portable international normalized ratio monitor in an outpatient anticoagulation clinic. Clin Lab Haematol 2004; 26: 49-55.
12. Poller L, Keown M, Ibrahim SA, Van der Meer FJ, Van den Besselaar AM, Tripodi A, et al. Quality assessment of CoaguChek point-of-care prothrombin time monitors: comparison of the European community-approved procedure and conventional external quality assessment. Clin Chem 2006; 52: 1843-7.
13. Jacobson AK. Warfarin monitoring: point-of-care INR testing limitations and interpretation of the prothrombin time. J Thromb Thrombolysis 2008; 25: 10-11.
14. Jackson SL, Peterson GM, House M, Bartlett T. Point-of-care monitoring of anticoagulant therapy by rural community pharmacists: description of successful outcomes. Aust J Rural Health 2004; 12: 197-200.
15. McLachlan AJ, Spindler M, Fois R, Krass I, Chen T, Bajorek BV. A community pharmacy based anticoagulation management service. Canberra: Pharmacy Guild of Australia); 2005.
16. Jackson SL, Peterson GM, Bereznicki LR, Misan GM, Jupe DM, Vial JH. Improving the outcomes of anticoagulation in rural Australia: an evaluation of pharmacist-assisted monitoring of warfarin therapy. J Clin Pharm Ther 2005; 30: 345-53.
17. Macik BG. The future of anticoagulation clinics. J Thromb Thrombolysis 2003; 16: 55-9.
18. Samsa GP, Matchar DB. Relationship between test frequency and outcomes of anticoagulation: a literature review and commentary with implications for the design ofrandomized trials of patient self-management. J Thromb Thrombolysis 2000; 9: 283-92.
19. Bajorek BK, Krass I, Ogle SJ, Duguid MJ, Shenfield GM. Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: a pharmacist-led multidisciplinary intervention. J Am Geriatr Soc 2005; 53: 1912-20.
20. Ford PW, Close A. Management of warfarin in atrial fibrillation. Med J Aust 2007; 187: 371.
21. Coleman B, Martin C, Barber N, Patterson D. An evaluation ofthe safety and acceptability of an anticoagulation clinic in a community pharmacy setting - a pilot study. Pharm J 2004; 273: 822-4.
22. Amruso NA. Ability of clinical pharmacists in a community pharmacy setting to manage anticoagulation therapy. J Am Pharm Assoc 2004; 44: 467-71.
23. Bajorek BV, Ogle SJ, Duguid MJ, Shenfield GM, Krass I. Management of warfarin in atrial fibrillation: views of health professionals, older patients and their carets. Med J Aust 2007; 186: 175-80.
24. Biscup-Horn PJ, Streiff MB, Ulbrich TR, Nesbit TW, Shermock KM. Impact of an inpatient anticoagulation management service on clinical outcomes. Ann Pharmacother 2008; 42: 777-82.
25. Smythe MA. Advances in anticoagulation management: the role of pharmacy. Ann Pharmacother 2007; 41: 493-5.